JAZZ vs XMTR · P/E 1988, rev $2.28B vs rev $434.4M
Jazz Pharmaceuticals PLC (JAZZ) versus Xometry Inc (XMTR) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Xometry Inc (XMTR) is a industrial distribution company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported XMTR revenue for 2026-06-30 was $434.4M. Net income was -$10.6M. XMTR currently screens at market cap $4.81B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. XMTR currently screens at market cap $4.81B.
Not investment advice. Open the JAZZ and XMTR stock pages for the full models.
Not investment advice.